These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25545687)

  • 21. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
    Bryceson YT; Ljunggren HG; Long EO
    Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.
    Kim HS; Das A; Gross CC; Bryceson YT; Long EO
    Immunity; 2010 Feb; 32(2):175-86. PubMed ID: 20189481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
    Roda-Navarro P; Reyburn HT
    J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.
    Nedvetzki S; Sowinski S; Eagle RA; Harris J; Vély F; Pende D; Trowsdale J; Vivier E; Gordon S; Davis DM
    Blood; 2007 May; 109(9):3776-85. PubMed ID: 17218381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells.
    Endt J; Eissmann P; Hoffmann SC; Meinke S; Giese T; Watzl C
    Eur J Immunol; 2007 Jan; 37(1):193-8. PubMed ID: 17171759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of NKp30- and 2B4-mediated NK cell activation by evolutionary different human and bovine CEACAM1 receptors.
    Merkt W; Urlaub D; Meinke S; Kammerer R; Watzl C
    Eur J Immunol; 2015 Jul; 45(7):2134-42. PubMed ID: 25824372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation.
    Fortenbery NR; Paraiso KH; Taniguchi M; Brooks C; Ibrahim L; Kerr WG
    J Immunol; 2010 May; 184(9):5065-74. PubMed ID: 20363967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
    J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
    Margraf-Schönfeld S; Böhm C; Watzl C
    J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.
    Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R
    Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of the dual functions of 2B4 (CD244).
    Chlewicki LK; Velikovsky CA; Balakrishnan V; Mariuzza RA; Kumar V
    J Immunol; 2008 Jun; 180(12):8159-67. PubMed ID: 18523281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.
    Hernández-Caselles T; Miguel RC; Ruiz-Alcaraz AJ; García-Peñarrubia P
    J Immunol Res; 2019; 2019():6032141. PubMed ID: 31143782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.
    Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D
    Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.
    Vacca P; Pietra G; Falco M; Romeo E; Bottino C; Bellora F; Prefumo F; Fulcheri E; Venturini PL; Costa M; Moretta A; Moretta L; Mingari MC
    Blood; 2006 Dec; 108(13):4078-85. PubMed ID: 16931625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.